MiNK Therapeutics, Inc.

NASDAQ
INKT
Stock
Yield per half year: +856.81%
Dividend yield: 0%
Sector: Healthcare

Share chart MiNK Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About MiNK Therapeutics, Inc.

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. It's product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 2021-10-15
ISIN US6036931029
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт link
Цена ао 7.1
Change price per day: -5.49% (7.29)
Change price per week: -10.52% (7.7)
Change price per month: -8.13% (7.5)
Change price per 3 month: -26.03% (9.315)
Change price per half year: +856.81% (0.7201)
Change price per year: +632.98% (0.94)
Change price per 3 year: +425.95% (1.31)
Change price per year to date: +30.52% (5.279)
All parameters

Grade

Underestimation
Title Value Grade
P/S 0.0222 10
P/BV -1.94 0
P/E 0 0
EV/EBITDA -1.4 0
Total: 5
Efficiency
Title Value Grade
ROA, % -493.33 0
ROE, % 124.38 10
Total: 3.33
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0
Debt
Title Value Grade
Debt/EBITDA 0 10
Total: 10
Growth impulse
Title Value Grade
Yield Revenue, % 391891.74 10
Yield Ebitda, % 0.2398 1
Yield EPS, % -35.29 0
Total: 2.4
More

Main owners

Institutions Volume Share, %
Vanguard Group Inc 234 182 0.67
Longbow Finance Sa 166 666 0.48
Renaissance Technologies, LLC 92 041 0.27
Geode Capital Management, LLC 90 164 0.26
Blackrock Inc. 76 457 0.22
CapTrust Financial Advisors 54 291 0.16
HighTower Advisors, LLC 50 941 0.15
Citadel Advisors Llc 42 141 0.12
Oracle Investment Management Inc 36 898 0.11
State Street Corporation 25 700 0.07

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Dr. Garo H. Armen Ph.D. Executive Chairman N/A 1953 (72 years)
Dr. Jennifer S. Buell Ph.D. President, CEO & Director 916.75k 1975 (50 years)
Dr. Marcus Antonius van Dijk Ph.D. Chief Scientific Officer 458.28k 1962 (63 years)
Ms. Christine M. Klaskin Treasurer 29.62k 1966 (59 years)
Joy Zhou Ph.D. Vice President & Head of CMC N/A
Mr. Robert Foster Director Of Legal & Business Affairs

About company

Address: United States, New York. NY, 149 Fifth Avenue - Open in google maps, Open in yandex maps
Website: https://minktherapeutics.com